Epidemiological studies of oats consumption and risk of cancer and overall mortality

Paolo Boffetta; Frank Thies; Penny Kris-Etherton

doi:10.1017/S0007114514002268

Epidemiological studies of oats consumption and risk of cancer and overall mortality

Paolo Boffetta, Frank Thies, Penny Kris-Etherton

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

9 Downloads (Pure)

Abstract

A review of epidemiological studies on the intake of oats and oat-based products and its effect on the risk of chronic disease and deaths was performed. Seven studies were identified of cancer risk (two each on prostate and colorectal cancer, and one each on pancreatic, breast and endometrial cancer), and one study on overall mortality. With the exception of a case-control study of pancreatic cancer, all studies were of cohort design: five studies were based on a single cohort from Denmark. The results of most cohort studies suggest a weak protective effect of a high intake of oats on cancer risk (relative risks in the order of 0·9). Potential limitations of the studies are dietary exposure misclassification, low statistical power because of limited exposure contrast and residual confounding. Despite the evidence from experimental and mechanistic studies of a protective effect of oats intake on CVD and diabetes, no epidemiological studies have been conducted on these conditions.

Original language	English
Pages (from-to)	S14-S18
Number of pages	5
Journal	British Journal of Nutrition
Volume	112
Issue number	Suppl 2
Early online date	30 Sept 2014
DOIs	https://doi.org/10.1017/S0007114514002268
Publication status	Published - Oct 2014

Bibliographical note

Acknowledgements

P. B., F. T. and P. K.-E. each received an honorarium from Quaker Oats Company (a subsidiary of PepsiCo, Inc.) for attending a workshop in May 2012 to discuss the content of the supplement. P. B. (Icahn School of Medicine at Mount Sinai), F. T. (University of Aberdeen) and P. K.-E. (Pennsylvania State University) received unrestricted grants from Quaker Oats Company.

The authors’ contributions are as follows: P. B., F. T. and P. K.-E. conceived the review; P. B. extracted the data and prepared the first draft of the paper. All authors reviewed and commented on the paper.

This paper was published as part of a supplement to British Journal of Nutrition, publication of which was supported by an unrestricted educational grant from Quaker Oats Co. (a subsidiary of PepsiCo Inc.). The papers included in this supplement were invited by the Guest Editor and have undergone the standard journal formal review process. They may be cited.

Keywords

Avena
Breast Neoplasms
Colorectal Neoplasms
Diet
Edible Grain
Endometrial Neoplasms
Epidemiologic Studies
Female
Humans
Male
Neoplasms
Prostatic Neoplasms
Risk
Journal Article
Research Support, Non-U.S. Gov't
Review
Oats
Neoplasm
Epidemiology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1017/S0007114514002268Licence: Unspecified

Cite this

@article{c724534fb8db4e08a1ce06a8b34acfb5,

title = "Epidemiological studies of oats consumption and risk of cancer and overall mortality",

abstract = "A review of epidemiological studies on the intake of oats and oat-based products and its effect on the risk of chronic disease and deaths was performed. Seven studies were identified of cancer risk (two each on prostate and colorectal cancer, and one each on pancreatic, breast and endometrial cancer), and one study on overall mortality. With the exception of a case-control study of pancreatic cancer, all studies were of cohort design: five studies were based on a single cohort from Denmark. The results of most cohort studies suggest a weak protective effect of a high intake of oats on cancer risk (relative risks in the order of 0·9). Potential limitations of the studies are dietary exposure misclassification, low statistical power because of limited exposure contrast and residual confounding. Despite the evidence from experimental and mechanistic studies of a protective effect of oats intake on CVD and diabetes, no epidemiological studies have been conducted on these conditions.",

keywords = "Avena, Breast Neoplasms, Colorectal Neoplasms, Diet, Edible Grain, Endometrial Neoplasms, Epidemiologic Studies, Female, Humans, Male, Neoplasms, Prostatic Neoplasms, Risk, Journal Article, Research Support, Non-U.S. Gov't, Review, Oats , Neoplasm, Epidemiology",

author = "Paolo Boffetta and Frank Thies and Penny Kris-Etherton",

note = " Acknowledgements P. B., F. T. and P. K.-E. each received an honorarium from Quaker Oats Company (a subsidiary of PepsiCo, Inc.) for attending a workshop in May 2012 to discuss the content of the supplement. P. B. (Icahn School of Medicine at Mount Sinai), F. T. (University of Aberdeen) and P. K.-E. (Pennsylvania State University) received unrestricted grants from Quaker Oats Company. The authors{\textquoteright} contributions are as follows: P. B., F. T. and P. K.-E. conceived the review; P. B. extracted the data and prepared the first draft of the paper. All authors reviewed and commented on the paper. This paper was published as part of a supplement to British Journal of Nutrition, publication of which was supported by an unrestricted educational grant from Quaker Oats Co. (a subsidiary of PepsiCo Inc.). The papers included in this supplement were invited by the Guest Editor and have undergone the standard journal formal review process. They may be cited.",

year = "2014",

month = oct,

doi = "10.1017/S0007114514002268",

language = "English",

volume = "112",

pages = "S14--S18",

journal = "British Journal of Nutrition",

issn = "0007-1145",

publisher = "Cambridge University Press",

number = "Suppl 2",

}

TY - JOUR

T1 - Epidemiological studies of oats consumption and risk of cancer and overall mortality

AU - Boffetta, Paolo

AU - Thies, Frank

AU - Kris-Etherton, Penny

N1 - Acknowledgements P. B., F. T. and P. K.-E. each received an honorarium from Quaker Oats Company (a subsidiary of PepsiCo, Inc.) for attending a workshop in May 2012 to discuss the content of the supplement. P. B. (Icahn School of Medicine at Mount Sinai), F. T. (University of Aberdeen) and P. K.-E. (Pennsylvania State University) received unrestricted grants from Quaker Oats Company. The authors’ contributions are as follows: P. B., F. T. and P. K.-E. conceived the review; P. B. extracted the data and prepared the first draft of the paper. All authors reviewed and commented on the paper. This paper was published as part of a supplement to British Journal of Nutrition, publication of which was supported by an unrestricted educational grant from Quaker Oats Co. (a subsidiary of PepsiCo Inc.). The papers included in this supplement were invited by the Guest Editor and have undergone the standard journal formal review process. They may be cited.

PY - 2014/10

Y1 - 2014/10

N2 - A review of epidemiological studies on the intake of oats and oat-based products and its effect on the risk of chronic disease and deaths was performed. Seven studies were identified of cancer risk (two each on prostate and colorectal cancer, and one each on pancreatic, breast and endometrial cancer), and one study on overall mortality. With the exception of a case-control study of pancreatic cancer, all studies were of cohort design: five studies were based on a single cohort from Denmark. The results of most cohort studies suggest a weak protective effect of a high intake of oats on cancer risk (relative risks in the order of 0·9). Potential limitations of the studies are dietary exposure misclassification, low statistical power because of limited exposure contrast and residual confounding. Despite the evidence from experimental and mechanistic studies of a protective effect of oats intake on CVD and diabetes, no epidemiological studies have been conducted on these conditions.

AB - A review of epidemiological studies on the intake of oats and oat-based products and its effect on the risk of chronic disease and deaths was performed. Seven studies were identified of cancer risk (two each on prostate and colorectal cancer, and one each on pancreatic, breast and endometrial cancer), and one study on overall mortality. With the exception of a case-control study of pancreatic cancer, all studies were of cohort design: five studies were based on a single cohort from Denmark. The results of most cohort studies suggest a weak protective effect of a high intake of oats on cancer risk (relative risks in the order of 0·9). Potential limitations of the studies are dietary exposure misclassification, low statistical power because of limited exposure contrast and residual confounding. Despite the evidence from experimental and mechanistic studies of a protective effect of oats intake on CVD and diabetes, no epidemiological studies have been conducted on these conditions.

KW - Avena

KW - Breast Neoplasms

KW - Colorectal Neoplasms

KW - Diet

KW - Edible Grain

KW - Endometrial Neoplasms

KW - Epidemiologic Studies

KW - Female

KW - Humans

KW - Male

KW - Neoplasms

KW - Prostatic Neoplasms

KW - Risk

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

KW - Review

KW - Oats

KW - Neoplasm

KW - Epidemiology

U2 - 10.1017/S0007114514002268

DO - 10.1017/S0007114514002268

M3 - Article

C2 - 25267240

SN - 0007-1145

VL - 112

SP - S14-S18

JO - British Journal of Nutrition

JF - British Journal of Nutrition

IS - Suppl 2

ER -

Epidemiological studies of oats consumption and risk of cancer and overall mortality

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this